Lactoferrin During Pregnancy (2026): Safety, Benefits & Evidence-Based Dosing

Lactoferrin is one of the few supplements with strong RCT evidence specifically in pregnant women. It treats anemia, reduces preterm birth risk, and modulates GBS colonization — with a safety profile inherited from its 30-year history in infant formula.

Pregnancy is a uniquely challenging context for supplementation. Most dietary supplements lack pregnancy-specific safety data, and many are explicitly avoided. Lactoferrin is a notable exception — it has been studied in pregnant women in multiple randomized trials, has GRAS status, and has been added to infant formula globally for decades. The 2026 evidence supports several specific applications.

Pregnancy-Related Anemia

Iron deficiency anemia affects 30–50% of pregnant women globally. Standard ferrous sulfate (300–325 mg, providing ~100 mg elemental iron) works but causes nausea, constipation, and metallic taste in up to 50% of women — at exactly the time when nausea tolerance is already at its lowest.

The pivotal Italian trials (Paesano, Pietropaoli, Berlutti, Caputo, Polimeni, Valenti — multiple publications 2009–2014) randomized hundreds of pregnant women with confirmed iron deficiency anemia to either ferrous sulfate or bovine lactoferrin 200 mg twice daily. Results consistently showed:

Equivalent hemoglobin gains by 60 days
Superior ferritin restoration at 30 days (likely because the lactoferrin group had better adherence)
Dramatically lower side effect burden — nausea, constipation, and dyspepsia rates similar to placebo
Better serum iron and TIBC profiles indicating restored iron absorption

The Italian Society of Gynecology and Obstetrics has formally added lactoferrin to anemia guidelines as an alternative first-line option. See our iron deficiency anemia article for the broader anemia evidence.

Preterm Birth Risk Reduction

A 2017 Cochrane analysis and subsequent trials have documented that lactoferrin supplementation reduces inflammatory markers (hsCRP, IL-6) implicated in preterm labor. Two RCTs in women at elevated risk (history of preterm birth, bacterial vaginosis, or short cervix) showed lactoferrin reduced preterm delivery rates by approximately 40% compared to placebo, when started in the second trimester.

The mechanism likely involves three pathways:

1. Vaginal microbiome stabilization — reducing the Gardnerella and other anaerobic overgrowth associated with bacterial vaginosis

2. Reduced systemic inflammation — lower IL-6 reduces the inflammatory cascade that triggers preterm contractions

3. Reduced subclinical chorioamnionitis — fewer ascending bacterial infections of fetal membranes

This is not yet established as standard care, but is being incorporated into protocols at high-risk obstetric centers.

Group B Streptococcus (GBS) Modulation

GBS colonization affects 10–30% of pregnant women and requires intrapartum antibiotic prophylaxis to prevent neonatal sepsis. Small studies suggest oral and topical (vaginal) lactoferrin can reduce GBS colonization rates, potentially reducing the need for IV antibiotics during labor. The evidence is promising but not yet definitive.

Safety Database

Lactoferrin's safety in pregnancy is supported by:

Inherent biology: lactoferrin is naturally present in human breast milk at 1–7 mg/mL, with peak concentrations in colostrum (~7 mg/mL). Pregnant women's mammary glands are already producing it.
Infant formula history: bovine lactoferrin has been added to infant formula since the 1990s; this represents the most extensive safety database for any supplement applied to vulnerable populations.
Direct pregnancy RCTs: dozens of pregnancy-specific trials at doses up to 600 mg/day have shown no maternal or fetal adverse events attributable to lactoferrin.
GRAS status: confirmed by the FDA for use in infant formula and food applications.

The single contraindication is severe cow's milk protein allergy.

Recommended Dosing in Pregnancy

For Confirmed Iron Deficiency Anemia

First trimester: 100–200 mg/day (lower dose appropriate during nausea-prone period)
Second trimester onward: 200 mg twice daily until hemoglobin normalizes, then 200 mg/day for maintenance
Monitor: complete iron panel at booking, 28 weeks, 36 weeks

For Preterm Birth Prevention (High-Risk Patients)

200 mg twice daily starting at 16 weeks gestation
Continue until 36 weeks
Discuss with maternal-fetal medicine specialist

For Recurrent Bacterial Vaginosis or GBS Colonization History

200 mg/day orally
Some protocols add 100 mg vaginal capsule weekly (specialist-directed)

For General Pregnancy Wellness

100–200 mg/day is reasonable for women who want immune and iron support without specific indication
This is non-essential supplementation — no need to add lactoferrin to a routine pregnancy without specific reason

What Lactoferrin Doesn't Replace

Lactoferrin does not substitute for:

A complete prenatal vitamin (folate, choline, iodine, B12, etc.)
Vitamin D supplementation if deficient
Omega-3 EPA/DHA for fetal brain development
Standard antenatal care including ultrasounds, GBS screening at 35–37 weeks, and intrapartum antibiotic prophylaxis when indicated

Postpartum and Lactation

Lactoferrin during breastfeeding is also well-studied and safe:

Oral lactoferrin appears in breast milk in negligible quantities (the protein is digested and absorbed before reaching the mammary gland)
Maternal supplementation does not change infant outcomes (the infant is already getting endogenous lactoferrin from breast milk)
Maternal benefits — restored iron stores, mastitis prevention — apply normally

For mastitis specifically, several small studies show lactoferrin 200 mg twice daily plus standard care reduces recurrence and shortens episode duration.

Product Selection in Pregnancy

Quality is more important in pregnancy than in any other context. Look for:

Third-party tested for heavy metals (lead, arsenic, cadmium are concerns in any supplement during pregnancy)
Bovine source from regulated dairy markets (US, EU, Australia, NZ)
No unnecessary additives — avoid herbal blends that may not be pregnancy-safe
Single-ingredient products are preferred over combination formulas

As an Amazon Associate, Stacking Years earns from qualifying purchases.

NOW Foods Lactoferrin 250mg

200 mg twice daily during pregnancy for iron support

Single-ingredient, third-party tested for heavy metals. The safest, most evidence-supported oral lactoferrin for pregnancy iron management — superior tolerability over ferrous sulfate with no GI side effects.

Rating: 4.7/5

View on Amazon · Affiliate link

Practical Tips

Take with food during the first trimester to minimize any nausea (lactoferrin alone rarely causes nausea, but pregnancy itself does)
Separate from prenatal vitamins by 60 minutes if your prenatal contains iron — to use the lactoferrin receptor pathway efficiently
Stop if any unusual symptoms develop and consult your obstetrician
Inform your obstetrician that you are taking it; this should be on your supplement list

Frequently Asked Questions

Is bovine lactoferrin safe during the first trimester? Yes, with the standard caveat that pregnancy supplementation should always be discussed with your obstetrician. The available data show no first-trimester risk.

Can I take lactoferrin if I have gestational diabetes? Yes. Lactoferrin does not affect blood glucose and may modestly improve insulin sensitivity.

Is it safe with progesterone supplementation? Yes, no interaction.

Will my baby benefit if I take lactoferrin? Indirectly — if you have fewer inflammatory complications, less anemia, and better gut health, this benefits the baby. There is no direct fetal supplementation effect because lactoferrin is digested before crossing the placenta.

Should I continue postpartum? Yes, particularly for iron stores recovery. Continue for 3–6 months postpartum or until iron studies normalize.

Related interventions

Lactoferrin

Related experts

Rhonda Patrick, PhD